Zhang Lei, Liu Xiaoyan, Xia Rong, Chen Fei, Wang Xin, Bao Jia, Shao Yongzhao, Lu Xian, Wang Yan, Wang Jili, Tun May Thu, Melamed Jonathan, Lepor Hebert, Deng Fang-Ming, Wang Dongwen, Ren Guoping
Department of Urology, The First Hospital of Shangxi Medical University, Shanxi, China.
Department of Pathology, The First Hospital of Zhejiang University, Zhejiang, China.
Pathol Res Pract. 2022 Jun;234:153933. doi: 10.1016/j.prp.2022.153933. Epub 2022 May 1.
Prostate cancer (PCa) is the most common malignant tumor found among men in the United States. Incidence rates of PCa have recently grown in Asian countries, partially due to the comprehensive implementation of early detection systems. Interestingly, a prospective cohort study showed that adopting a westernized dietary pattern was associated with a higher risk of being diagnosed with PCa among Korean and Japanese men. However, a comparison of current clinicopathological features of PCa between American and Chinese men is lacking. In this study, we report the current clinicopathological features of PCa in Chinese men and compare them to those of patients in the USA.
Case cohorts included, in total, 871 PCa cases with prostatectomy sequentially treated since 2017, including 299 cases from USA and 572 cases from two different academic hospitals in China. The parameters, including patient's age, preoperative Prostate-Specific Antigen (PSA) level, Gleason score, Grade Group, stage and tumor focality, were collected, analyzed and compared using two sample t-test, Wilcoxon rank sum test, Pearson's Chi-squared test and Fisher's exact test.
Significant differences were demonstrated in the mean age of patients, preoperative PSA levels, extra-prostatic extension, Gleason scores, and Grade Groups (p < 0.05). PCa patients in the Chinese group were older than patients in the USA group (67.81 vs. 63.53, p < 0.01). The preoperative PSA levels in the Chinese group were higher than those in the USA group (11.69 v.s 6.30, p < 0.01). A higher percentage of high Grade Groups (Groups 4 and 5) was observed in the Chinese group (25.7%) compared to the USA cohort (17.11%), while Grade Group 2 was more common in the USA group than in the Chinese group (51.68% vs. 32.52%, p < 0.01).
All these data suggest that the clinicopathologic features of PCa are different between the USA and Chinese populations, which may be influenced by treatment strategies (including surgical case selection criteria).
前列腺癌(PCa)是美国男性中最常见的恶性肿瘤。近年来,亚洲国家的前列腺癌发病率有所上升,部分原因是早期检测系统的全面实施。有趣的是,一项前瞻性队列研究表明,在韩国和日本男性中,采用西式饮食模式与被诊断为前列腺癌的较高风险相关。然而,目前缺乏对美国男性和中国男性前列腺癌临床病理特征的比较。在本研究中,我们报告了中国男性前列腺癌的当前临床病理特征,并将其与美国患者的特征进行比较。
病例队列总共包括自2017年以来接受前列腺切除术的871例前列腺癌病例,其中包括来自美国的299例和来自中国两家不同学术医院的572例。收集患者年龄、术前前列腺特异性抗原(PSA)水平、Gleason评分、分级组、分期和肿瘤灶性等参数,使用两样本t检验、Wilcoxon秩和检验、Pearson卡方检验和Fisher精确检验进行分析和比较。
患者的平均年龄、术前PSA水平、前列腺外侵犯、Gleason评分和分级组存在显著差异(p < 0.05)。中国组前列腺癌患者比美国组患者年龄更大(67.81对63.53,p < 0.01)。中国组术前PSA水平高于美国组(11.69对6.30,p < 0.01)。与美国队列(17.11%)相比,中国组中高分级组(4级和5级)的比例更高(25.7%),而2级在美国组中比在中国组中更常见(51.68%对32.52%,p < 0.01)。
所有这些数据表明,美国和中国人群中前列腺癌的临床病理特征不同,这可能受治疗策略(包括手术病例选择标准)的影响。